Affinity Asset Advisors »

Assembly Biosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Assembly Biosciences (ASMB) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Assembly Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Assembly Biosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Assembly Biosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.2M 190k 27.48

More positions owned by Affinity Asset Advisors

Roivant Sciences SHS (ROIV)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Alkermes SHS (ALKS)
Insmed Com Par $.01 (INSM)
Moderna Put Option (MRNA)
Praxis Precision Medicines I Com New (PRAX)
Oruka Therapeutics (ORKA)
Anaptysbio Inc Common (ANAB)
Avalo Therapeutics Com New (AVTX)
Cytokinetics Com New (CYTK)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Affinity Asset Advisors

Top funds holding Assembly Biosciences

Gilead Sciences
Farallon Capital Management
Paradigm Biocapital Advisors
Commodore Capital
RA Capital Management
Jupiter Topco
Henderson Group
BlackRock
Parkman Healthcare Partners
Vanguard Capital Management
Point72 Asset Management
Seven Fleet Capital Management
Millennium Management
Geode Capital Management
Schonfeld Strategic Advisors

View all funds holding Assembly Biosciences